These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10849738)

  • 1. N-terminal HIV-1 Tat nonapeptides as inhibitors of dipeptidyl peptidase IV. Conformational characterization.
    Mrestani-Klaus C; Fengler A; Faust J; Brandt W; Wrenger S; Reinhold D; Ansorge S; Neubert K
    Adv Exp Med Biol; 2000; 477():125-9. PubMed ID: 10849738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonapeptides derived from the N-terminal structure of human immunodeficiency virus-1 (HIV-1) Tat on suppression of CD26-dependent T cell growth.
    Wrenger S; Reinhold D; Faust J; Mrestani-Klaus C; Brandt W; Fengler A; Neubert K; Ansorge S
    Adv Exp Med Biol; 2000; 477():161-5. PubMed ID: 10849743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth.
    Wrenger S; Hoffmann T; Faust J; Mrestani-Klaus C; Brandt W; Neubert K; Kraft M; Olek S; Frank R; Ansorge S; Reinhold D
    J Biol Chem; 1997 Nov; 272(48):30283-8. PubMed ID: 9374514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1H NMR conformational study on N-terminal nonapeptide sequences of HIV-1 Tat protein: a contribution to structure-activity relationships.
    Mrestani-Klaus C; Fengler A; Brandt W; Faust J; Wrenger S; Reinhold D; Ansorge S; Neubert K
    J Pept Sci; 1998 Sep; 4(6):400-10. PubMed ID: 9796859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26).
    Weihofen WA; Liu J; Reutter W; Saenger W; Fan H
    J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation of N-terminal HIV-1 Tat (fragment 1-9) peptide by NMR and MD simulations.
    Kanyalkar M; Srivastava S; Coutinho E
    J Pept Sci; 2001 Nov; 7(11):579-87. PubMed ID: 11763362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal X-X-Pro sequence of the HIV-1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen-induced proliferation of human T cells.
    Wrenger S; Reinhold D; Hoffmann T; Kraft M; Frank R; Faust J; Neubert K; Ansorge S
    FEBS Lett; 1996 Apr; 383(3):145-9. PubMed ID: 8925885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.
    Lorey S; Stöckel-Maschek A; Faust J; Brandt W; Stiebitz B; Gorrell MD; Kähne T; Mrestani-Klaus C; Wrenger S; Reinhold D; Ansorge S; Neubert K
    Eur J Biochem; 2003 May; 270(10):2147-56. PubMed ID: 12752434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition.
    Stöckel-Maschek A; Stiebitz B; Born I; Faust J; Mögelin W; Neubert K
    Adv Exp Med Biol; 2000; 477():117-23. PubMed ID: 10849737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function.
    Wrenger S; Faust J; Mrestani-Klaus C; Brandt W; Thielitz A; Neubert K; Reinhold D
    Front Biosci; 2008 May; 13():3194-201. PubMed ID: 18508427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor.
    Wrenger S; Faust J; Mrestani-Klaus C; Fengler A; Stockel-Maschek A; Lorey S; Kahne T; Brandt W; Neubert K; Ansorge S; Reinhold D
    J Biol Chem; 2000 Jul; 275(29):22180-6. PubMed ID: 10896952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.
    Gutheil WG; Subramanyam M; Flentke GR; Sanford DG; Munoz E; Huber BT; Bachovchin WW
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6594-8. PubMed ID: 7912830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
    Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
    Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.
    Fan H; Tansi FL; Weihofen WA; Böttcher C; Hu J; Martinez J; Saenger W; Reutter W
    Eur J Cell Biol; 2012 Apr; 91(4):265-73. PubMed ID: 21856036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete 1H nuclear magnetic resonance assignments and structural characterization of a fusion protein of the alpha-amylase inhibitor tendamistat with the activation domain of the human immunodeficiency virus type 1 Tat protein.
    Freund J; Vértesy L; Koller KP; Wolber V; Heintz D; Kalbitzer HR
    J Mol Biol; 1995 Jul; 250(5):672-88. PubMed ID: 7623384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Tat targets TAR: structure of the BIV peptide-RNA complex.
    Greenbaum NL
    Structure; 1996 Jan; 4(1):5-9. PubMed ID: 8805518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy.
    Shojania S; O'Neil JD
    J Biol Chem; 2006 Mar; 281(13):8347-56. PubMed ID: 16423825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.